|Autoimmune Connective Tissue Diseases
||The Autoimmune Connective Tissue Diseases Group’s research focuses on a series of overlapping systemic diseases which result in inflammation of multiple organs. Through the use of laboratory studies, clinical trials and outcome measures research this group’s research topics cover a broad range of themes, from novel imaging tools to elucidating the role type I interferons play in the pathogenesis of a range of autoimmune diseases.
|Foot and Ankle Studies in Rheumatology
||The Leeds Foot and Ankle Studies (FASTER) initiative is a strategic programme based on development of fundamental science, novel outcome measures, conduct of randomised controlled trials, and coordinated activity which aims to improve foot care services nationwide.
||World class imaging in rheumatic and musculoskeletal diseases.
||The unit has the principle of accurate phenotyping to predict prognosis through all stages of disease. The ultimate ambition is prevention of disease. The work is based on a nationwide network of primary care referrals. Arthritis prevention centres are being developed. Several stratified intervention studies have been undertaken.
||Our research group aims to improve the treatment and outcomes of people with common disorders such as osteoarthritis, tendinitis and multisite joint pain (the commonest presentation of people over 50, representing a mixture of osteoarthritis and tendinitis affecting multiple joints).
|Orthopaedics and Trauma Sciences
||Leeds Orthopaedics and Trauma Sciences is based at the University of Leeds and is part of LIRMM. It conducts, leads and collaborates in cutting edge research in musculoskeletal conditions. The group has secured funding in excess of 20 million from various grant bodies, charitable trusts as well as industry. Its current areas of translational research are in osteoarthritis, fractures, related large data sets, international health, sensor technology and patient outcomes.